A. Karolina Palucka

Jackson Laboratory — United States

Immunology and Microbiology · Life Sciences

43h-index14.0kcitations85works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(55), T-cell and B-cell Immunology(34), Cancer Immunotherapy and Biomarkers(27), Immune Cell Function and Interaction(20), vaccines and immunoinformatics approaches(14)

Publications85 total

Abstract NG11: Autologous humanized PDX modeling for immuno-oncology recapitulates the human tumor microenvironment
Cancer Research·2023
Table S1 from IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer
2023Open Access
Table S4 from IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer
2023Open Access
Data from IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer
2023Open Access
Table S2 from IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer
2023Open Access
Supplementary figures from IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer
2023Open Access
Supplementary figures from IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer
2023Open Access
Table S4 from IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer
2023Open Access
Table S5 from IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer
2023Open Access
Table S3 from IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer
2023Open Access
Table S3 from IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer
2023Open Access
Table S5 from IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer
2023Open Access
Table S2 from IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer
2023Open Access
Data from IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer
2023Open Access
Table S1 from IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer
2023Open Access
Calculating sample size for identifying cell subpopulation in single-cell RNA-seq experiments
2019· 1 citedOpen Access
Abstract B015: Expansion and activation of CD103+ dendritic cell progenitors at the tumor site transform tumor response to PD-L1 and BRAF inhibition
Cancer Immunology Research·2016· 2 cited
ICOS+PD-1+CXCR3+ T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination
Scientific Reports·2016· 181 citedOpen Access
Cancer cell-derived transforming growth factor (TGF)-β and myeloid cell-derived interleukin (IL)-1β synergize to promote type 2 inflammation and breast cancer progression
The Journal of Immunology·2016
Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
Immunity·2016· 1.1k citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Jacques Banchereau(37), Hideki Ueno(14), Joseph W. Fay(11), Virginia Pascual(7), Madhav V. Dhodapkar(7), John E. Connolly(6), Sophie Paczesny(5), Virginia Pascual(4), Francesco M. Marincola(4), Eynav Klechevsky(4), Caroline Aspord(4), Lynda Bennett(4), Gérard Zurawski(4), Patrick Blanco(3), Sacha Gnjatic(3), Gaëtan Jégo(3), Susan Burkeholder(3), Damien Chaussabel(3), Nathalie Schmitt(3), Jean‐Yves Blay(3)